These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 8832979)

  • 21. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
    Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
    Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced generation of endothelial cells from CD34+ cells of the bone marrow in rheumatoid arthritis: possible role in synovial neovascularization.
    Hirohata S; Yanagida T; Nampei A; Kunugiza Y; Hashimoto H; Tomita T; Yoshikawa H; Ochi T
    Arthritis Rheum; 2004 Dec; 50(12):3888-96. PubMed ID: 15593185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice.
    Blin-Wakkach C; Wakkach A; Rochet N; Carle GF
    J Bone Miner Res; 2004 Jul; 19(7):1137-43. PubMed ID: 15176997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly-, CD14-, CD17-, colony-forming cell.
    Agis H; Willheim M; Sperr WR; Wilfing A; Krömer E; Kabrna E; Spanblöchl E; Strobl H; Geissler K; Spittler A; Boltz-Nitulescu G; Majdic O; Lechner K; Valent P
    J Immunol; 1993 Oct; 151(8):4221-7. PubMed ID: 7691941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of angiotensin II on hematopoietic progenitor cell proliferation.
    Rodgers KE; Xiong S; Steer R; diZerega GS
    Stem Cells; 2000; 18(4):287-94. PubMed ID: 10924095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine-regulated expression of activated leukocyte cell adhesion molecule (CD166) on monocyte-lineage cells and in rheumatoid arthritis synovium.
    Levesque MC; Heinly CS; Whichard LP; Patel DD
    Arthritis Rheum; 1998 Dec; 41(12):2221-9. PubMed ID: 9870879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the dendritic cell-associated C-type lectin DC-SIGN by inflammatory matrix metalloproteinase-producing macrophages in rheumatoid arthritis synovium and interaction with intercellular adhesion molecule 3-positive T cells.
    van Lent PL; Figdor CG; Barrera P; van Ginkel K; Slöetjes A; van den Berg WB; Torensma R
    Arthritis Rheum; 2003 Feb; 48(2):360-9. PubMed ID: 12571844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of mRNA for nuclear factor kappaB1 (p50) in CD34+ cells of the bone marrow in rheumatoid arthritis.
    Hirohata S; Miura Y; Tomita T; Yoshikawa H; Ochi T; Chiorazzi N
    Arthritis Res Ther; 2006; 8(2):R54. PubMed ID: 16519794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
    Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.